PROSTATE CANCER

A basic treatment programs
Prostate cancer treatment can be divided into surgical treatment, hormonal therapy, radiotherapy, chemotherapy and treatment in Chinese medicine. Specific selection of the program, according to the patient's age, systemic symptoms, the cancer staging, state immunity and comprehensive consideration. General radical surgery for early adopters, five-year survival rate 75% 10 55% survival rate, 15-year survival rate of 33%. The frail elderly or have complications or pelvic metastasis of patients, radiotherapy should be OK, five-year survival rates of 60%, 10-year survival rate 39%. Using advanced endocrine, chemical treatment and Chinese medicine.

The prostate is wrapping men beneath the bladder, urethra around the size of an iron-like gland for men unique. According to statistics, China's annual 7 ~ 80,000 new cases of prostate cancer, 95% occurred in people older than 60, prostate cancer incidence continued to increase with increasing age. Clinical found that prostate cancer occurred in the posterior lobe, and no more early symptoms, even some discomfort, would not be enough to cause the patient's attention. When the tumor increased urethral compression, often confused with BPH. The club, about 80% of the patients first discovered lesions distant metastasis, and then found that prostate cancer. At this time, advanced lesions have a poor prognosis. Thus, the early detection of prostate cancer is clearly important.

The University of Michigan Medical School and his colleagues, Dr. JB Ammori that radiotherapy combined gemcitabine (Gem / RT) as a new means of adjuvant therapy is expected for patients with advanced pancreatic cancer, but its side effects limit its application.

Japan's Tokyo Komagome Hospital Dr. Okamoto and his colleagues selected 144 cases of pancreatic cancer patients, intraoperative radiotherapy and analysis of the efficacy of radiation therapy. Patients were divided into 2 groups: group 1 included 65 patients with unresectable tumors using shunt surgery; Group 2 included 68 cases of patients with tumor resection. In addition, the PWC study, 11 patients with radiation therapy from around the hemodynamic changes of pancreatic arterial infusion chemotherapy after them.

Some men with prostate cancer have a special virus in vivo study found that the virus may contribute to prostate cancer treatment. This virus researchers from the University of California found. The researchers first selected 86 patients with carcinoma of the prostate cancer specimens, through their invention of the "virus fragments (Virochip)" technology, found a new virus. "Virus fragment" technology has been used to confirm the SARS virus. According to reports, the new structure of the virus in mice with leukemia virus similar Branch. Experiments also found that 20 genes are defective in patients with prostate cancer, eight were found in the virus. Not found in patients with other viruses. As for this exists in the mouse chromosome how the virus appeared in humans, scientists have not yet fully understood.

Urological Institute Europe (EAU) in the first prostate cancer treatment guidelines published in 2001. In the past few years, whenever affect prostate cancer (CaP) clinical treatment of the important changes, EAU Guide will be updated. In August 2005, EAU again updated the prostate cancer treatment guidelines. From www.uroweb.org new website will be a complete version of the Guide.